Related Experiment Videos
Idiosyncratic reaction to bleomycin in an epithelial tumor
Cancer Chemotherapy and Pharmacology
|January 1, 1984
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
British journal of cancer·2014
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer.
European journal of cancer (Oxford, England : 1990)·2012
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.
British journal of cancer·2011
Adjuvant levamisole and fluorouracil in high risk colorectal cancer patients.
Oncology reports·2011
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026
Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.
Cancer chemotherapy and pharmacology·2026
Pharmacological inhibition of store-operated calcium entry enhances sorafenib-induced antitumor effects in Huh7 hepatocellular carcinoma cells.
Cancer chemotherapy and pharmacology·2026
Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database.
Cancer chemotherapy and pharmacology·2026
Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review.
Cancer chemotherapy and pharmacology·2026
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
[Analysis of clinicopathological and immunological characteristics of patients with acquired immune deficiency syndrome-associated diffuse large B-cell lymphoma complicated by Talaromyces marneffei infection].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026